Person

Jay S. Skyler

Formerly Director, Dexcom

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$27.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • DXCM
    Dexcom
    Director
    May 2016 – last filing May 2023

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 22, 2021DXCMSale6,264$425.45$2.7M
Jun 22, 2021DXCMSale8,334$426.56$3.6M
Jun 22, 2021DXCMSale5,402$427.14$2.3M
Jan 3, 2020DXCMSale5,564$217.31$1.2M
Jan 3, 2020DXCMSale14,456$218.14$3.2M
Jan 3, 2020DXCMSale3,086$218.94$676K
Jan 3, 2020DXCMSale2,700$216.16$584K
May 14, 2018DXCMSale30,000$88.00$2.6M
May 8, 2018DXCMSale31,464$85.11$2.7M
Mar 6, 2017DXCMSale31,890$78.13$2.5M
Sep 12, 2016DXCMSale10,000$93.00$930K
Sep 9, 2016DXCMSale25,000$94.07$2.4M
Aug 19, 2016DXCMSale25,000$90.77$2.3M

SEC reporting-owner ID (CIK) 1236386 · all filings on EDGAR

Jay S. Skyler | USBoard